Amicus Therapeutics Inc
NASDAQ:FOLD

Watchlist Manager
Amicus Therapeutics Inc Logo
Amicus Therapeutics Inc
NASDAQ:FOLD
Watchlist
Price: 11.42 USD -1.38% Market Closed
Market Cap: 3.4B USD
Have any thoughts about
Amicus Therapeutics Inc?
Write Note

Amicus Therapeutics Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amicus Therapeutics Inc
Change in Working Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Amicus Therapeutics Inc
NASDAQ:FOLD
Change in Working Capital
-$43.3m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Change in Working Capital
-$49m
CAGR 3-Years
70%
CAGR 5-Years
49%
CAGR 10-Years
5%
Gilead Sciences Inc
NASDAQ:GILD
Change in Working Capital
-$4.1B
CAGR 3-Years
-20%
CAGR 5-Years
-28%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Change in Working Capital
-$1.4B
CAGR 3-Years
-10%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Change in Working Capital
-$762.1m
CAGR 3-Years
-28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Change in Working Capital
-$721.7m
CAGR 3-Years
45%
CAGR 5-Years
-15%
CAGR 10-Years
N/A

See Also

What is Amicus Therapeutics Inc's Change in Working Capital?
Change in Working Capital
-43.3m USD

Based on the financial report for Jun 30, 2024, Amicus Therapeutics Inc's Change in Working Capital amounts to -43.3m USD.

What is Amicus Therapeutics Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
-11%

Over the last year, the Change in Working Capital growth was 38%. The average annual Change in Working Capital growth rates for Amicus Therapeutics Inc have been -11% over the past three years .

Back to Top